These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 24599253)

  • 1. Metformin and other antidiabetic agents in renal failure patients.
    Lalau JD; Arnouts P; Sharif A; De Broe ME
    Kidney Int; 2015 Feb; 87(2):308-22. PubMed ID: 24599253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):383-94. PubMed ID: 22313172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metformin is also recommended in mild and moderate renal failure].
    Zechmann S
    Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
    [No Abstract]   [Full Text] [Related]  

  • 4. Can genetics improve precision of therapy in diabetes?
    Groop L; Storm P; Rosengren A
    Trends Endocrinol Metab; 2014 Sep; 25(9):440-3. PubMed ID: 25028244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
    Chu PY; Hackstadt AJ; Chipman J; Griffin MR; Hung AM; Greevy RA; Grijalva CG; Elasy T; Roumie CL
    Diabetes Care; 2020 Jul; 43(7):1462-1470. PubMed ID: 32327421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm.
    Lalau JD; Kajbaf F; Protti A; Christensen MM; De Broe ME; Wiernsperger N
    Diabetes Obes Metab; 2017 Nov; 19(11):1502-1512. PubMed ID: 28417525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.
    Harrower AD
    Clin Pharmacokinet; 1996 Aug; 31(2):111-9. PubMed ID: 8853933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Roussel R; Lorraine J; Rodriguez A; Salaun-Martin C
    Adv Ther; 2015 Nov; 32(11):1029-64. PubMed ID: 26581749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs].
    Scheen AJ
    Rev Med Liege; 2002 May; 57(5):352-6. PubMed ID: 12143186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2013 May; 9(5):529-50. PubMed ID: 23461781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):839-57. PubMed ID: 24669954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Update: New Pharmacotherapy for Type 2 Diabetes.
    Choby B
    FP Essent; 2017 May; 456():27-35. PubMed ID: 28530382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure.
    Di Grande A; Vancheri F; Giustolisi V; Giuffrida C; Narbone G; Licata M; Le Moli C; Riccobene S; Burgio A; Bartolotta S; Nigro F; Cannone V
    Clin Ter; 2008; 159(2):87-9. PubMed ID: 18463766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
    van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
    J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation?
    Runge S; Mayerle J; Warnke C; Robinson D; Roser M; Felix SB; Friesecke S
    Diabetes Obes Metab; 2008 Jan; 10(1):91-3. PubMed ID: 18095950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Nyström T; Nathanson D
    Lakartidningen; 2018 Feb; 115():. PubMed ID: 29461581
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metformin and kidney].
    Sessa C; Blanco J; Granata A; Fatuzzo P; Castellino P; Zanoli L
    G Ital Nefrol; 2016; 33(3):. PubMed ID: 27374392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral combination therapy in primary care.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2015 May; 65(5):574-5. PubMed ID: 26028398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactic acidosis induced by metformin: incidence, management and prevention.
    Lalau JD
    Drug Saf; 2010 Sep; 33(9):727-40. PubMed ID: 20701406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.